Mar-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Remedi's performance across different categories in Illinois shows a varied trajectory. In the Capsules category, Remedi was ranked 7th in December 2024, but they did not appear in the top 30 in subsequent months, indicating a potential decline in their market presence or a shift in consumer preferences. Conversely, in the Concentrates category, Remedi demonstrated resilience by maintaining a presence in the top 20, with a notable rebound to the 14th position in March 2025 after a dip in February. Meanwhile, the Tincture & Sublingual category remains a stronghold for Remedi, consistently holding the 3rd rank over the four-month period, suggesting a stable consumer base and effective product positioning.
In Massachusetts, Remedi's performance in the Concentrates category reflects a downward trend. Starting at the 25th rank in December 2024, the brand slipped to the 29th position by March 2025. This decline could be attributed to increased competition or changing market dynamics, which might have impacted their sales volume. Despite this, the brand managed to maintain a presence within the top 30, indicating that while they face challenges, they still hold a significant market share. The fluctuations in rankings suggest that Remedi may need to reassess its strategies in Massachusetts to regain upward momentum.
Competitive Landscape
In the competitive landscape of concentrates in Illinois, Remedi has experienced notable fluctuations in its market position from December 2024 to March 2025. Initially ranked 14th, Remedi saw a decline to 17th and 18th in January and February, respectively, before rebounding to 14th in March. This volatility in rank reflects a challenging market environment, with competitors such as Shelby County Community Services consistently maintaining a higher rank, fluctuating between 10th and 12th place. Meanwhile, Avexia showed a steady climb, moving from 18th to 12th, indicating a strengthening market presence. Remedi's sales mirrored its rank changes, with a significant dip in February, followed by a recovery in March, suggesting potential vulnerabilities in maintaining consistent sales momentum. The competitive pressures from brands like FloraCal Farms and IC Collective, which also showed varying ranks, highlight the dynamic nature of the concentrates market in Illinois, emphasizing the need for strategic adjustments to sustain and improve Remedi's market position.
Notable Products
In March 2025, the top-performing product for Remedi was the Indica Rest RSO Dropper (0.5g) in the Concentrates category, maintaining its position as the best-seller for three consecutive months with sales of 2468. The Indica Relief RSO Syringe (0.5g) followed closely, holding steady at the second rank, showing a recovery in sales from February. The Indica Rest RSO Syringe (0.5g) improved its standing to third place, demonstrating a positive trend in sales growth. The CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) remained consistent at fourth place, while the CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) rounded out the top five after being introduced in January. These rankings reflect a stable performance across Remedi's product line, with minor shifts indicating a steady consumer demand for their concentrates and tinctures.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.